Company Overview: Celsion

About the Company


Celsion is committed to the development of efficient, effective, and targeted therapies for the treatment of cancer and other difficult-to-treat diseases, with the goal of improving patient outcomes in underserved indications. Our extensive, complementary clinical pipeline, stretching from discovery to Phase III, is driven by innovative platform technologies in the areas of chemotherapy, immunotherapy, and DNA- and RNA-based therapy.

Investor Toolkit

Company News

Email Subscription


Follow this blog

Get every new post delivered right to your inbox.

Email address